Man Group’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,027,792
| Closed | -$22.5M | – | 1932 |
|
|
2025
Q1 | $22.5M | Buy |
1,027,792
+978,500
| +1,985% | +$21.4M | 0.06% | 346 |
|
|
2024
Q4 | $1.57M | Buy |
49,292
+32,550
| +194% | +$1.04M | ﹤0.01% | 1244 |
|
|
2024
Q3 | $483K | Sell |
16,742
-60,487
| -78% | -$1.74M | ﹤0.01% | 1528 |
|
|
2024
Q2 | $2.96M | Buy |
+77,229
| New | +$2.96M | 0.01% | 1102 |
|
|
2023
Q2 | – | Hold |
0
| – | -$274K | – | 1910 |
|
|
2023
Q1 | – | Sell |
-105,784
| Closed | -$5.47M | – | 1692 |
|
|
2022
Q4 | $5.47M | Sell |
105,784
-37,601
| -26% | -$1.94M | 0.02% | 796 |
|
|
2022
Q3 | $9.79M | Buy |
+143,385
| New | +$9.79M | 0.05% | 476 |
|
|
2022
Q2 | – | Sell |
-63,852
| Closed | -$3.24M | – | 1293 |
|
|
2022
Q1 | $3.24M | Buy |
+63,852
| New | +$3.24M | 0.01% | 1058 |
|
|
2021
Q4 | – | Sell |
-23,300
| Closed | -$768K | – | 1866 |
|
|
2021
Q3 | $768K | Sell |
23,300
-66,125
| -74% | -$2.18M | ﹤0.01% | 1413 |
|
|
2021
Q2 | $5.65M | Sell |
89,425
-95,649
| -52% | -$6.05M | 0.02% | 826 |
|
|
2021
Q1 | $7.94M | Sell |
185,074
-36,126
| -16% | -$1.55M | 0.03% | 502 |
|
|
2020
Q4 | $12.7M | Sell |
221,200
-26,686
| -11% | -$1.53M | 0.06% | 364 |
|
|
2020
Q3 | $7.48M | Sell |
247,886
-9,460
| -4% | -$285K | 0.03% | 605 |
|
|
2020
Q2 | $8.41M | Buy |
257,346
+244,384
| +1,885% | +$7.98M | 0.04% | 428 |
|
|
2020
Q1 | $347K | Buy |
+12,962
| New | +$347K | ﹤0.01% | 1350 |
|